CClinicalTrials.gg
CompletedNCT00347620Updated Mar 15, 2010

Improving Vision and Quality of Life in the Nursing Home

An interventional study of spectacles and Cataract Surgery in Refractive Error and Cataract, sponsored by University of Alabama at Birmingham. Completed at 17 sites in United States. Open to participants aged 60 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2010-03-15.

Sponsored by University of Alabama at Birmingham · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
400
Allocation
Randomized
Ages
60 Years and older
Sex
All
01

Study summary

The primary purpose of this study is to evaluate whether interventions to improve vision in nursing home residents have an impact on residents' health-related quality of life. The interventions being evaluated are correction of refractive error (near-sightedness, far-sightedness, presbyopia) and cataract surgery.

Read the detailed description

The purpose of this project is two-fold: 1.) to establish the psychometric properties of the Nursing Home Vision-Specific Health-Related Quality of Life (HRQOL) instrument, and; 2.) to evaluate the responsiveness of this instrument. Responsiveness will be assessed in two independent preliminary prospective intervention evaluations. The first responsiveness evaluation will involve a new spectacle intervention and the second will involve first eye cataract surgery. In addition, we will examine the association between the responsiveness of this instrument, and changes in visual functioning measures and other demographic variables.

02

Conditions studied

  • Refractive Error
  • Cataract
03

In context

Cataract

1,701 studies on the registry are indexed under Cataract; 230 are open to participants now.

This study's enrollment of 400 is above the median of 80 across 1,155 interventional studies indexed under Cataract.

Browse Cataract studies →

Lead sponsor

University of Alabama at Birmingham is the lead sponsor of 1,396 studies on the registry; 284 are open to participants now.

Of its 156 completed or terminated interventional studies of FDA-regulated products, 124 (79%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
60 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • at least 60 years of age or older
  • expected to stay in facility foe at least 8 months
  • stable medical condition
  • moderately cognitively impaired or better

Exclusion criteria

Exclusion Criteria:

  • those not meeting inclusion criteria
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Single group
Masking
None (open label)
Enrollment
400 participants

Interventions

  • Devicespectacles
  • ProcedureCataract Surgery
06

What researchers measure

Primary outcomes

  1. vision-targeted health-related quality of life

Secondary outcomes

  1. depression

  2. generic health-related quality of life

  3. functional independence

  4. participation in group activities

  5. physical activities

  6. falls

  7. life space

07

Study locations

17 sites
  • Integrated Health Services at Briarcliff
    Alabaster, Alabama 35007, United States
  • Shelby Ridge Nursing Home
    Alabaster, Alabama 35007, United States
  • Livingston Health Care Center
    Bessemer, Alabama 35020, United States
  • Southgate Village
    Bessemer, Alabama 35020, United States
  • Beverly Healthcare Meadowood
    Bessemer, Alabama 35023, United States
  • Fair Haven Retirement Center
    Birmingham, Alabama 35210, United States
  • Beverly Healthcare Center Forestdale
    Birmingham, Alabama 35214, United States
  • Beverly Healthcare East
    Birmingham, Alabama 35215, United States
  • South Haven
    Birmingham, Alabama 35226, United States
  • Fairview Health & Rehabilitation Center
    Birmingham, Alabama 35228, United States
  • Estes Nursing Facility Civic Center
    Birmingham, Alabama 35234, United States
  • Estes Nursing Facility Northway
    Birmingham, Alabama 35234, United States
  • Beverly Healthcare Riverchase
    Birmingham, Alabama 35244, United States
  • Beverly Health Care Center West
    Fairfield, Alabama 35964, United States
  • The Self Nursing Home, Inc
    Hueytown, Alabama 35023, United States
  • Beverly Healthcare Pleasant Grove
    Pleasant Grove, Alabama 35127, United States
  • Consult America Cottage Hills
    Pleasant Grove, Alabama 35127, United States
08

References and documents

Publications

  • Owsley C, McGwin G Jr, Scilley K, Meek GC, Seker D, Dyer A. Effect of refractive error correction on health-related quality of life and depression in older nursing home residents. Arch Ophthalmol. 2007 Nov;125(11):1471-7. doi: 10.1001/archopht.125.11.1471. PubMed 17998508 ↗
09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Mar 15, 2010, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT00347620
Lead sponsor
University of Alabama at Birmingham
Collaborators
Retirement Research Foundation, National Institute on Aging (NIA), National Eye Institute (NEI), Research to Prevent Blindness, EyeSight Foundation of Alabama, Pearle Vision Foundation
First posted
Jul 4, 2006
Start date
Aug 2000
Completion
Dec 2003
Last update
Mar 15, 2010

Study contacts

Cynthia Owsley, PhD, MSPH
principal investigator · University of Alabama at Birmingham
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Mar 2010. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion